A Novel Series of Flavone‐Cinnamic Acid Hybrid Derivatives as Hypoglycemic Agents: Design, Synthesis, and Activity Studies
Chemistry & Biodiversity · 2026-07 · 23 (7)
DOI: 10.1002/cbdv.71501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 27.07.2026. Verfasst von Xiangxiang Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Cinnamates, Flavones, Drug Design. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Integration of Traditional Chinese Medicine and Western Medicine Fund of the Tianjin Municipal Health Commission.
Abstract (Originalsprache)
In this work, α‐glucosidase was chosen as the main therapeutic target. Novel flavone‐cinnamic acid hybrid derivatives were designed, synthesized, and structurally identified based on flavone prototypes with intrinsic α‐glucosidase inhibitory effects. Considering the multi‐target pathological features of diabetes, α‐glucosidase inhibition, lipase inhibition, DPPH radical scavenging capacities, and insulin‐resistant HepG2 cell assays were systematically evaluated to clarify their hypoglycemic mechanisms. Most acacetin‐cinnamic acid hybrid derivatives exerted strong dual inhibitory effects on the two enzymes, with 6c and 6l showing the best α‐glucosidase and lipase inhibitory activity, respectively, at the concentration of 50 µM. In the baicalein‐cinnamic acid hybrid derivatives, only 7a possessed prominent lipase inhibition, while other analogues were weak in enzyme inhibition but superior to parent baicalein. Notably, baicalein‐cinnamic acid hybrid derivatives presented outstanding antioxidant activity, and significantly enhanced glucose uptake in insulin‐resistant HepG2 cells, among which 7f and 7i were the most promising candidates. Enzyme inhibition and antioxidant properties jointly determined their cellular hypoglycemic effects. Overall, these hybrids exert anti‐diabetic effects via synergistic multi‐pathway actions, and 7f and 7i deserve further in‐depth mechanistic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Tianjin Institute of Pharmaceutical Research Co., Ltd., Tianjin, China.
Förderung
- National Natural Science Foundation of China
- Integration of Traditional Chinese Medicine and Western Medicine Fund of the Tianjin Municipal Health Commission
Zitieren
APA
Zhao, X., Mou, J., Xiao, G., Zuo, J., Wang, L., & Deng, Y. (2026). A Novel Series of Flavone‐Cinnamic Acid Hybrid Derivatives as Hypoglycemic Agents: Design, Synthesis, and Activity Studies. Chemistry & Biodiversity, 23(7). https://doi.org/10.1002/cbdv.71501
Vancouver
Zhao X, Mou J, Xiao G, Zuo J, Wang L, Deng Y. A Novel Series of Flavone‐Cinnamic Acid Hybrid Derivatives as Hypoglycemic Agents: Design, Synthesis, and Activity Studies. Chemistry & Biodiversity. 2026;23(7). doi:10.1002/cbdv.71501
BibTeX
@article{Zhao2026,
author = {Zhao, Xiangxiang and Mou, Jiajia and Xiao, Guizhi and Zuo, Jiali and Wang, Lili and Deng, Yanru},
title = {A Novel Series of Flavone‐Cinnamic Acid Hybrid Derivatives as Hypoglycemic Agents: Design, Synthesis, and Activity Studies},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {7},
doi = {10.1002/cbdv.71501}
}
EUVIMED